Amphetamine-like drug Captagon is bringing big profits to Syria’s Assad regime and Hezbollah – globally, it’s worth $5.7billion – and it’s triggering a health crisis, the Wall Street Journal reported.
Amphetamine-like drug Captagon is bringing big profits to Syria’s Assad regime and Hezbollah – globally, it’s worth $5.7billion – and it’s triggering a health crisis, the Wall Street Journal reported.